Biotech and Pharmaceuticals
Lab-grown breast milk startup Biomilq aims to change infant nutrition — if it can release a product
Mother holding a newborn in a hospital bed. Svetikd | E+ | Getty Images In 2020, in a nondescript office building in Durham, North Carolina, a team of scientists used cells to recreate sugar and protein found in breast milk. The seemingly niche development could years later change the way infant nutrition is understood and […]
Read More
FDA advisors recommend Pfizer’s RSV vaccine for infants but raise safety concerns
Respiratory syncytial virus – viral vaccine under research Hailshadow | Istock | Getty Images The Food and Drug Administration’s independent panel of advisors on Thursday recommended full approval of Pfizer’s vaccine that protects infants from RSV, but raised safety concerns over premature births that may be tied to the shot. The committee unanimously said the […]
Read More
CDC urges mpox vaccination among people at high risk to prevent summer surge
Bottle of Vaccine for booster shot for Smallpox and Monkeypox MPXV. Angelp | Istock | Getty Images The Centers for Disease Control and Prevention on Thursday urged gay men and other individuals at high risk from mpox to get fully vaccinated to prevent a summer resurgence of the virus. The CDC’s call for those at […]
Read More
Horizon Therapeutics says Amgen deal could close earlier than planned if FTC fails to block it
Robert Galbraith | Reuters Horizon Therapeutics expects its $27.8 billion sale to Amgen to close as early as the end of the third quarter, earlier than previously planned — if the Federal Trade Commission’s attempt to block the deal fails — according to a document filed Thursday with the Securities and Exchange Commission. The FTC […]
Read More
NJ Gov. Murphy would look at defying Supreme Courtroom if justices again abortion tablet ban
New Jersey Gov. Phil Murphy Scott Mlyn | CNBC New Jersey Gov. Phil Murphy on Wednesday claimed he would take into account defying the Supreme Court docket and go on to present mifepristone if the court docket guidelines in favor of a ban on the abortion capsule. When questioned if the point out would prescribe […]
Read More
Pfizer to raise $31 billion in debt offering to fund Seagen acquisition, SEC filing shows
A logo for Pfizer is displayed on a monitor on the floor at the New York Stock Exchange, July 29, 2019. Brendan McDermid | Reuters Pfizer plans to raise $31 billion through a debt offering to fund its proposed acquisition of cancer drugmaker Seagen, for what would be its largest takeover since 2009, according to […]
Read More
Access to abortion pill mifepristone at stake in federal appeals court hearing
Mifepristone, the first medication in a medical abortion, is prepared for a patient at Alamo Women’s Clinic in Carbondale, Illinois, April 20, 2023. Evelyn Hockstein | Reuters A federal appeals court will hear arguments Wednesday afternoon in a closely watched lawsuit that seeks to pull the abortion pill mifepristone from the U.S. market. The hearing […]
Read More
Citi names its major biotech and pharma stock picks, offering one approximately 90% upside
The health care sector outperformed in Europe, India and China previous thirty day period, according to Citi, which named its major picks around the globe. Europe’s pharma sector appears to be significantly robust, the financial institution mentioned in a May 4 take note, with European big caps observing consensus earnings updates in April and favourable […]
Read More
Pfizer RSV vaccine for infants has ‘generally favorable’ safety data, FDA staff say
Blood sample for respiratory syncytial virus (RSV) test Jarun011 | Istock | Getty Images U.S. Food and Drug Administration staff on Tuesday said Pfizer’s vaccine that protects infants from respiratory syncytial virus has “generally favorable” safety data. The FDA staff made the conclusion in briefing documents ahead of a meeting on Thursday, when a panel […]
Read More
Oppenheimer says investors are missing opportunities in three biotech areas and the related stocks
As biopharma investors follow the latest buzz around advancements in clinical research, they may be under-appreciating opportunities in neurology, psychiatry and genetic medicine, according to a report from Oppenheimer. Specifically, analyst Jay Olson called out companies such as Biogen , Karuna Therapeutics and Crispr Therapeutics , among others. “Our analysis shows Genetic Medicine and Metabolic […]
Read More